|
NAUT Nautilus Biotechnology Inc 1808805 |
| Balance Sheet |
|
Current Assets
|
$87,626,000.00 |
|
Assets
|
$163,576,000.00 |
|
Current Liabilities
|
$8,639,000.00 |
|
Liabilities
|
$32,464,000.00 |
|
Equity
|
$131,112,000.00 |
|
Shares Out
|
127224640.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-26,826,000.00 |
|
Investing Cash Flow
|
$26,255,000.00 |
| Market Analysis |
Market Cap
|
$114,502,176.00 |
|
Price
|
$0.90 |
|
BVPS
|
1.03 |
|
PB
|
0.87 |
|
EPS
|
-0.11 |
|
PS
|
150.48 |
|
FCF
|
$-27,790,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:35 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.11 |
|
| Apr |
May |
Jun |
|
|
2026-04-28 |
-0.12 |
|
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-31 |
-0.12 |
|
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-28 |
-0.11 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NAUT documents filed with the SEC.
NAUT Filings
Clear
